AI assistant
Sending…
Nuwellis, Inc. — Director's Dealing 2012
Mar 2, 2012
35477_dirs_2012-03-02_c79cd4aa-5f74-4d8e-975a-2589f89ea26a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3/A — Form 3/A
Issuer: Sunshine Heart, Inc. (SSH)
CIK: 0001506492
Period of Report: 2012-02-14
Reporting Person: Callinan Nicholas (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 29647 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $16.2784 | 2018-07-09 | Common Stock (5000) | Direct | |
| Employee Stock Option (right to buy) | $20.348 | 2018-07-09 | Common Stock (5000) | Direct | |
| Employee Stock Option (right to buy) | $7.1218 | 2014-12-08 | Common Stock (19205) | Direct | |
| Common Stock Warrant (right to buy) | $6.5114 | 2014-12-08 | Common Stock (7500) | Indirect |
Footnotes
F1: This amendment corrects the number of shares beneficially owned.
F2: All shares beneficially owned by Beraleigh Pty Ltd., of which Mr. Callinan is a director.
F3: Fully vested.
F4: The option vests as to 1/48th of the shares each month with (i) 6 months of the shares vesting on August 18, 2011, and (ii) the remaining shares vesting equally for 42 consecutive months beginning September 17, 2011.
F5: Immediately exercisable.
More from Nuwellis, Inc.
Capital/Financing Update
2026
Jun 10
Capital/Financing Update
2026
Jun 8
Capital/Financing Update
2026
Jun 4
Investor Presentation
2026
Jun 1
Capital/Financing Update
2026
May 29
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 15
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2